Increased net prescription drug prices despite manufacturer discounts

Researchers have determined that between 2007 and 2018, net prescription drug prices rose more than three times faster than the rate of inflation, even accounting for manufacturer discounts. In a novel study, researchers from the Center for Pharmaceutical Policy and Prescribing at the University of Pittsburgh’s Health Policy Institute (PA, USA) have determined that, despite manufacturer discounts, the net costs of prescription drug prices rose significantly more rapidly compared with the rate of inflation between 2007 and 2018. Lead study author Inmaculada Hernandez (University of Pittsburgh) explained: “In prior work, we observed that prices of drugs more than doubled in...